secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2023-07-28T23:59:59+00:00
Accession:  0001628280-23-026002
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem Q2 sales $231.3M (-2.3% YoY); adjusted EPS $1.06; record EBITDA
-----------------------------------------------------------------------

- Q2 net sales $231.3M, down 2.3% YoY; GAAP net earnings $30.1M ($0.93 EPS).
- Record quarterly adjusted EBITDA $59.1M, up 4.6% YoY; adjusted EPS $1.06 (vs $1.07 prior year).
- Operating cash flow $35.0M; free cash flow $31.7M; repaid $26M revolving debt, net debt $338.7M.
- Leverage ratio 1.5x net debt; completed new Vitacholine manufacturing unit for choline production.
- Effective tax rate declined to 21.6% from 24.1% (255 bps lower).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000162828023026002/0001628280-23-026002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000162828023026002/bcpc-20230728.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-026002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer